UniProt ID | CHMP3_MOUSE | |
---|---|---|
UniProt AC | Q9CQ10 | |
Protein Name | Charged multivesicular body protein 3 | |
Gene Name | Chmp3 | |
Organism | Mus musculus (Mouse). | |
Sequence Length | 224 | |
Subcellular Localization |
Cytoplasm, cytosol. Membrane Lipid-anchor. Endosome. Late endosome membrane. Localizes to the midbody of dividing cells.. |
|
Protein Description | Probable core component of the endosomal sorting required for transport complex III (ESCRT-III) which is involved in multivesicular bodies (MVBs) formation and sorting of endosomal cargo proteins into MVBs. MVBs contain intraluminal vesicles (ILVs) that are generated by invagination and scission from the limiting membrane of the endosome and mostly are delivered to lysosomes enabling degradation of membrane proteins, such as stimulated growth factor receptors, lysosomal enzymes and lipids. The MVB pathway appears to require the sequential function of ESCRT-O, -I,-II and -III complexes. ESCRT-III proteins mostly dissociate from the invaginating membrane before the ILV is released. The ESCRT machinery also functions in topologically equivalent membrane fission events, such as the terminal stages of cytokinesis. ESCRT-III proteins are believed to mediate the necessary vesicle extrusion and/or membrane fission activities, possibly in conjunction with the AAA ATPase VPS4. Selectively binds to phosphatidylinositol 3,5-bisphosphate PtdIns(3,5)P2 and PtdIns(3,4)P2 in preference to other phosphoinositides tested. Involved in late stages of cytokinesis. Plays a role in endosomal sorting/trafficking of EGF receptor (By similarity).. | |
Protein Sequence | MGLFGKTQEKPPKELVNEWSLKIRKEMRVVDRQIRDIQREEEKVKRSVKDAAKKGQKEVCVVLAKEMIRSRKAVSKLYASKAHMNSVLMGMKNQLAVLRVAGSLQKSTEVMKAMQSLVKIPEIQATMRELSKEMMKAGIIEEMLEDTFESMDDQEEMEEAAEMEIDRILFEITAGALGKAPSKVTDALPEPEPAGAMAASEEGEEEEDEEDLEAMQSRLATLRS | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Myristoylation | ------MGLFGKTQE ------CCCCCCCCC | 29.70 | - | |
20 | Phosphorylation | KELVNEWSLKIRKEM HHHHHHHHHHHHHHH | 17.38 | 29514104 | |
60 | Glutathionylation | KKGQKEVCVVLAKEM HCCCHHHHHHHHHHH | 1.51 | 24333276 | |
112 | Ubiquitination | QKSTEVMKAMQSLVK HHHHHHHHHHHHHHC | 45.97 | 22790023 | |
185 | Phosphorylation | GKAPSKVTDALPEPE CCCCCCCCCCCCCCC | 21.20 | 25619855 | |
200 | Phosphorylation | PAGAMAASEEGEEEE CCCCCCCCCCCCCCC | 27.00 | 27087446 | |
217 | Phosphorylation | EDLEAMQSRLATLRS HHHHHHHHHHHHHCC | 19.04 | 25619855 | |
221 | Phosphorylation | AMQSRLATLRS---- HHHHHHHHHCC---- | 27.56 | 26643407 | |
224 | Phosphorylation | SRLATLRS------- HHHHHHCC------- | 47.92 | 26643407 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of CHMP3_MOUSE !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of CHMP3_MOUSE !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of CHMP3_MOUSE !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
CHM4B_HUMAN | CHMP4B | physical | 20360068 | |
ZEP1_HUMAN | HIVEP1 | physical | 26496610 | |
NSF_HUMAN | NSF | physical | 26496610 | |
FUBP1_HUMAN | FUBP1 | physical | 26496610 | |
BRE1B_HUMAN | RNF40 | physical | 26496610 | |
DHRS2_HUMAN | DHRS2 | physical | 26496610 | |
SNUT2_HUMAN | USP39 | physical | 26496610 | |
B4GT7_HUMAN | B4GALT7 | physical | 26496610 | |
DNJC8_HUMAN | DNAJC8 | physical | 26496610 | |
MDN1_HUMAN | MDN1 | physical | 26496610 | |
PRDX5_HUMAN | PRDX5 | physical | 26496610 | |
FABD_HUMAN | MCAT | physical | 26496610 | |
PF21A_HUMAN | PHF21A | physical | 26496610 | |
DTL_HUMAN | DTL | physical | 26496610 | |
KDM3A_HUMAN | KDM3A | physical | 26496610 | |
IPO4_HUMAN | IPO4 | physical | 26496610 | |
ZMYM1_HUMAN | ZMYM1 | physical | 26496610 | |
MED25_HUMAN | MED25 | physical | 26496610 |
Kegg Drug | ||||||
---|---|---|---|---|---|---|
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...